These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23820940)

  • 1. Global coagulation in myeloproliferative neoplasms.
    Tripodi A; Chantarangkul V; Gianniello F; Clerici M; Lemma L; Padovan L; Gatti L; Mannucci PM; Peyvandi F
    Ann Hematol; 2013 Dec; 92(12):1633-9. PubMed ID: 23820940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
    Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM
    J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry.
    Indirli R; Ferrante E; Scalambrino E; Profka E; Clerici M; Lettera T; Serban AL; Vena W; Pizzocaro A; Bonomi M; Cangiano B; Carosi G; Mazziotti G; Persani L; Lania A; Arosio M; Peyvandi F; Mantovani G; Tripodi A
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1660-e1672. PubMed ID: 33382882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
    Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
    Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.
    Panova-Noeva M; Marchetti M; Spronk HM; Russo L; Diani E; Finazzi G; Salmoiraghi S; Rambaldi A; Barbui T; Ten Cate H; Falanga A
    Am J Hematol; 2011 Apr; 86(4):337-42. PubMed ID: 21442635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procoagulant imbalance in patients with non-alcoholic fatty liver disease.
    Tripodi A; Fracanzani AL; Primignani M; Chantarangkul V; Clerici M; Mannucci PM; Peyvandi F; Bertelli C; Valenti L; Fargion S
    J Hepatol; 2014 Jul; 61(1):148-54. PubMed ID: 24657400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN).
    Giaccherini C; Verzeroli C; Marchetti M; Gamba S; Piras F; Russo L; Tessarolo S; Vignoli A; Finazzi G; Rambaldi A; Falanga A
    Thromb Res; 2016 Apr; 140 Suppl 1():S185-6. PubMed ID: 27161713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
    Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters.
    Tripodi A; Primignani M; Chantarangkul V; Viscardi Y; Dell'Era A; Fabris FM; Mannucci PM
    Thromb Res; 2009 May; 124(1):132-6. PubMed ID: 19135704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
    Tripodi A
    Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboelastometry changes in myeloproliferative neoplasms-surrogate for a procoagulant haemostatic imbalance or a consequence of technical reasons? : Comment on A. Tripodi et al. Ann Hematol (2013) 92:1633-1639.
    Nagler M; Ten Cate H
    Ann Hematol; 2014 Oct; 93(10):1781-2. PubMed ID: 25163411
    [No Abstract]   [Full Text] [Related]  

  • 12. An evaluation of global coagulation assays in myeloproliferative neoplasm.
    Lim HY; Ng C; Rigano J; Tacey M; Donnan G; Nandurkar H; Ho P
    Blood Coagul Fibrinolysis; 2018 Apr; 29(3):300-306. PubMed ID: 29538005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dkk3 levels in patients with myeloproliferative neoplasms.
    Medinger M; Muesser P; Girsberger S; Skoda R; Tzankov A; Buser A; Passweg J; Tsakiris DΑ
    Thromb Res; 2014 Feb; 133(2):218-21. PubMed ID: 24309205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation and rotational thromboelastometry in the healthy adult population.
    Schneider T; Siegemund T; Siegemund R; Petros S
    Hamostaseologie; 2015; 35(2):181-6. PubMed ID: 25529462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Determinants of Thrombin Generation Measured in Presence and Absence of Platelets-Results from the Gutenberg Health Study.
    Panova-Noeva M; Schulz A; Spronk HM; Beicht A; Laubert-Reh D; van Oerle R; Arnold N; Prochaska JH; Blettner M; Beutel M; Pfeiffer N; Münzel T; Lackner KJ; Ten Cate H; Wild PS
    Thromb Haemost; 2018 May; 118(5):873-882. PubMed ID: 29614519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of coagulation kinetics using thromboelastometry-methodologic influence of activator and test medium.
    Sørensen B; Fenger-Eriksen C; Christiansen K; Larsen OH; Ingerslev J
    Ann Hematol; 2010 Nov; 89(11):1155-61. PubMed ID: 20480163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics.
    Tarandovskiy ID; Balandina AN; Kopylov KG; Konyashina NI; Kumskova MA; Panteleev MA; Ataullakhanov FI
    Thromb Res; 2013 Jun; 131(6):e274-80. PubMed ID: 23611257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
    Rusak T; Piszcz J; Misztal T; Brańska-Januszewska J; Tomasiak M
    Thromb Res; 2014 Jul; 134(1):192-8. PubMed ID: 24824295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.